ZBZehra Neslişah Unan Bacak

Zehra Neslişah Unan Bacak

*This is an algorithmically generated author record based on publicly available information.

Zehra Neslişah Unan Bacak has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Changes in Quality of Life After Treatment for Non-Melanoma Skin Cancer: A Prospective Cohort Study

    by Ferdi Öztürk, Zehra Neslişah Unan Bacak, Egenaz Şenol Okan, Ümmühan Şeker, Kenan Aydoğan, Serkan Yazici, Süleyman Çeçen, Beyhan Cengiz Özyurt, Hayriye Sarıcaoğlu

    Background/Objectives: Non-melanoma skin cancer (NMSC), particularly basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), may adversely affect quality of life (QoL), especially in cosmetically sensitive areas. This study aimed to identify factors associated with QoL in patients with NMSC and to evaluate changes in dermatology- and skin cancer-specific QoL following treatment. Methods: This prospective study included 169 patients with NMSC evaluated at baseline and 3 months after treatment using the Dermatology Life Quality Index (DLQI) and Skin Cancer Quality of Life Impact Tool (SCQOLIT). Factors associated with baseline QoL and changes according to treatment modality and histological subtype were analysed. Results: The mean age was 69.2 ± 11.85 years; 82.8% had BCC and 17.2% had SCC. Mean DLQI scores decreased from 2.29 ± 2.81 to 0.34 ± 0.75 and SCQOLIT scores from 4.78 ± 5.53 to 1.20 ± 1.76 at 3 months (both p < 0.001). Lower educational level was associated with higher baseline DLQI scores, whereas younger age and higher socioeconomic status were associated with higher and lower baseline SCQOLIT scores, respectively; these associations persisted in sensitivity analyses. The associations of younger age, female sex, and SCC histology with higher DLQI scores were less robust. SCC patients had higher baseline DLQI scores than BCC patients (3.66 ± 4.82 vs. 2.01 ± 2.10, p = 0.040), but this difference was no longer statistically significant at 3 months. QoL improved following both surgical and medical treatment, with no significant differences in the magnitude of improvement among surgical or medical treatment types. Conclusions: QoL improved significantly within 3 months after NMSC treatment. Different factors were associated with baseline DLQI and SCQOLIT scores, suggesting that these instruments may capture complementary aspects of QoL. Their combined use may provide a more comprehensive assessment of patients with NMSC.

  • p-Coumaric acid has an ameliorative effect on peptic ulcer: a macroscopic, microscopic and biochemical analysis

    by Meltem Kolgazi, Gulsen Oztosun, Muge Yalcin, Zehra Neslisah Unan, Edanur Arsoy, Simge Oral, Sumeyye Cilingir, Merve Acikel Elmas, Serap Arbak

    Objective: p-Coumaric acid is commonly found in edible plants in nature and is known to be an effective antioxidant. This study aimed to investigate the therapeutic effects of p-coumaric acid on ethanol-induced gastric ulcer model Materials and Methods: After an 18-hour starvation period, the ulcer was induced in male Sprague-Dawley (250-300) rats by intragastric administration of 75% ethanol. An hour after ulcer induction, p-coumaric acid (250 mg/kg) suspended in 1 ml tween-80 was administered intragastrically. The control and ulcer groups received 1 ml tween-80. One hour later, all rats were euthanized and stomach samples were collected for macroscopic examination, histological evaluation, and measurement of myeloperoxidase (MPO) activity, malondialdehyde (MDA), and glutathione (GSH) levels. Results: Ethanol induction resulted in gastric epithelial and mucosal injury, increased MPO activity and MDA levels; and decreased GSH levels. Treatment with p-coumaric acid at a dose of 250 mg/kg markedly improved the gastric injury macroscopically, microscopically, and biochemically due to decreasing MPO activity and MDA levels while increasing GSH levels. Conclusion: p-Coumaric acid markedly ameliorated the gastric epithelial and mucosal injury induced by ethanol. The therapeutic effects of p-coumaric acid could be due to its antioxidant properties and protective role against GSH depletion and neutrophil accumulation.